Ursolic acid: An overview on its cytotoxic activities against breast and colorectal cancer cells

Eric Wei Chiang Chan, Chu Yong Soon, Joash Ban Lee Tan, Siu Kuin Wong, Yew Woh Hui

    Research output: Contribution to journalReview ArticleResearchpeer-review

    13 Citations (Scopus)

    Abstract

    Ursolic acid (UA) is a pentacyclic triterpene of the ursane type. As a common chemical constituent among species of the family Lamiaceae, UA possesses a broad spectrum of pharmacological properties. This overview focuses on the anticancer properties of UA against breast cancer (BC) and colorectal cancer (CRC) that are most common among women and men, respectively. In vitro studies have shown that UA inhibited the growth of BC and CRC cell lines through various molecular targets and signaling pathways. There are several in vivo studies on the cytotoxic activity of UA against BC and CRC. UA also inhibits the growth of other types of cancer. Studies on structural modifications of UA have shown that the –OH groups at C3 and at C28 are critical factors influencing the cytotoxic activity of UA and its derivatives. Some needs for future research are suggested. Sources of information were from ScienceDirect, Google Scholar and PubMed.

    Original languageEnglish
    Pages (from-to)155-160
    Number of pages6
    JournalJournal of Integrative Medicine
    Volume17
    Issue number3
    DOIs
    Publication statusPublished - May 2019

    Keywords

    • Cytotoxic
    • Molecular targets
    • Signaling pathways
    • Ursolic acid

    Cite this